• Transplant outcome reporting

  • Transplant outcome reporting

  • Transplant outcome reporting

#Outcome Reporting #Middle East

Live Session:

Friday, August 20, 2021 - 7:00 PM (Local time in Beirut)
Local time (Corresponding local time at your current location)

Join us:


Register

Description:


In accordance with the Istanbul Declaration, the Middle East Society of Organ Transplantation (MESOT) decided to establish a transplant registry as a requirement for transparency. Based on the success of other registries around the world the task seemed to be simple. The initial target was just to have a yearly number and a cumulative one.  despite many attempts, the registry which is vital for the promotion of deceased programs has not been sacksful due to many obstacles which will be highlighted.

Faculty:


Transparency the key to success


Marti Manyalich

Assessor on Transplantation, Medical Direction
Hospital Clinic, Barcelona
Associate Professor, Medical School
University of Barcelona
Barcelona, Spain

MD, PhD, anesthesiologist, is Assessor on Transplantation, Medical Direction, Hospital Clinic, Barcelona; Associate Professor, Medical School, University of Barcelona; and President of the TPM-DTI Foundation, Past President ISODP-TTS and TTS European Councilor. He created the deceased and living donation program in the Hospital Clinic of Barcelona in 1985and the TSF multi-tissue bank in 1994. He is an expert in organ and tissue donation, training donor procurement, and tissue banking at national and international level. Among the most important positions he has occupied, he was the former president of the European Transplant Coordinators Organization (ETCO, the former vice president of the European Association of Tissue Banks (EATB) and, from 2015 until September 2017, he was the President of the International Society for Organ Donation and Procurement (ISODP). He is currently European Councilor of The Transplantation Society (TTS) for 2018-2022 and Chair of the TTS Anesthesia and Critical Care Committee (2020-2022).

 

Registry obstacles and solutions


Marwan Masri

President Mediterranean Transplant Network (MTN)
CEO Transmedical For Life S.A.R.L
CEO Transmedical For Life Canada
Beirut, Lebanon

Professor Marwan Masri is a world-renowned figure in the field of organ transplantation, and drug evaluation, especially for cancer and immunotherapy drugs. Professor Masri has a Ph.D. in Medical Immunopathology; he is currently the CEO of Transmedical For Life S.A.R.L, the president of the Mediterranean Transplant Network (MTN), the past president of the Asian Society of Transplantation (AST), the immediate past president of the Middle East Society for Organ Transplantation (MESOT). He is a member of the Declaration of Istanbul custodian group (DICG), the International Transplant Society (ITS) ethic committee member, Coordinator of the Stem Cell therapy clinical trial group, and head of the MESOT registry. He is the Associate Editor of Experimental and Clinical transplantation, Drug and therapeutic, I.J. of enzymology and China medical Journal and is currently serving on many editorial boards for international medical journals such as Transplantation proceedings and was its guest editor for the years 2002, 2003, 2010 and 2013.

 

Schedule (90 min):


  • 05 min

    Welcome and introduction by the Chair
  • 25 min

    Presentation: Transparency the key to success, Marti Manyalich, Spain

  • 05 min

    Live Q&A with Marti Manyalich, Spain

  • 25 min

    Presentation: Registry obstacles and solutions, Marwan Masri, Lebanon

  • 05 min

    Live Q&A with Marwan Masri, Lebanon

  • 20 min

    Interactive panel discussion with audience participation led by the Chair
  • 05 min

    Masterclass closing remarks

Join Our Mailing List


Invalid Input
Invalid Input
Invalid email address

Please select at least one of the newsletters

Ask a Question


Invalid Input
Invalid Input
Invalid email address
Please type in your question

Masterclass Prospectus Request


Submit the following information to receive the downloadable prospectus instantaneously.

Invalid Input
Invalid Input
Invalid email address
Invalid Input
Invalid Input